Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39 pseudogene 33 (RPL39P33) is one of the multiple processed pseudogenes related to the functional ribosomal protein L39 gene. RPL39P33 does not encode an active protein or participate in ribosomal structure or function. It is considered a non-functional segment of DNA, likely derived from retrotransposition or duplication events during evolution. Pseudogenes like RPL39P33 generally have no direct biological activity, clinical relevance, or therapeutic utility, though the functional RPL39 gene encodes a protein involved in ribosome assembly and protein synthesis. In biomedical research and drug discovery, the term "RPL39P33" should not be confused with functional ribosomal proteins, receptors, or drug targets.
None (not applicable for pseudogenes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39 pseudogene 33 (RPL39P33).